Regional experts gather at HKBU forum to discuss development of Chinese medicine
11 Jun 2018
To explore the competitive advantages of using Traditional Chinese Medicine (TCM) for prevention and treatment, and how to leverage the opportunities offered by the Belt and Road Initiative to promote Chinese medicine in countries along the Belt and Road trail, the Taiwan, Hong Kong and Macao Chinese Medicine Exchange and Cooperation Centre of the State Administration of Traditional Chinese Medicine (SATCM) and HKBU joined hands to organise the Fourth Forum (Hong Kong) on the Development of Chinese Medicine on 3 June on HKBU campus. This is enabled by the collaborative efforts of the School of Chinese Medicine (SCM) of HKBU and Pok Oi Hospital.
Carrying the theme “Promoting Techniques of Preventing and Treating Diseases for which Chinese Medicines has Advantages; Contributing to Belt and Road Initiative”, the forum attracted a 500-strong audience comprising government officials, leading figures in the Chinese medicine sector, Chinese medicine practitioners, students and teachers of SCM. A total of 12 scholars and experts from the Chinese mainland, Hong Kong, Taiwan and Macao were invited to shed light on their latest research findings in the treatment of diseases in which TCM has advantages, including malignant lymphoma, rheumatism, geriatric diseases, cervical spondylosis, knee pain, and more. They also elaborated on how the Greater Bay Area could seize the opportunities presented by the Belt and Road Initiative to promote Chinese medicine, and how Taiwan and Macao could ride on the Initiative to foster the development of Chinese medicine.
The officiating party of the opening ceremony included Mr Zhang Weijia, Deputy Head of Department of Personnel Education of SATCM; Professor Sophia Chan, Secretary for Food and Health of HKSAR Government; Dr Chan Hon-yee, Director of Health of HKSAR Government; Mr Li Shangqing, Deputy Director of Taiwan, Hong Kong and Macao Chinese Medicine Exchange and Cooperation Centre of SATCM; Professor Rick Wong, Vice-President (Research and Development) of HKBU; Professor Zhao Zhongzhen, Acting Dean of SCM of HKBU; Mr Lee Yuk-fat, Chairman of Board of Directors of Pok Oi Hospital; Professor Leung Ting-hung, Director of SCM of The Chinese University of Hong Kong; Professor Shen Jiangang, Associate Director of SCM of The University of Hong Kong; Mr Xu Qingfeng, Vice Director of Health and Family Planning Commission of Guangdong Province and Director of Traditional Chinese Medicine Bureau of Guangdong Province; Mr Wu Yichang, President of Taiwan and China Cross-Strait Antrodia Cinnamomea Industrial Development Association; Mr Shi Chongrong, President of Macau Association of Chinese Medicine Practitioners; Mr Chen Junfeng, Director of Coordination Department of the Liaison Office of the Central People’s Government in HKSAR; Dr Zhu En, President of Hong Kong Registered Chinese Medicine Practitioners Association; Mr Ouyang Bo, Vice Director of China Traditional Chinese Medicine Newspaper; Mr Li Fung-cheung, Chairman of Executive Council of Kowloon Chamber of Commerce; and Ms Ma Ninghui, Vice Director of Department of International Cooperation (Hong Kong, Macao and Taiwan Affairs Office) of SATCM.
Speaking at the ceremony, Mr Zhang Weijia said that while Chinese medicine had spread to 183 countries and regions, the number of overseas Chinese medicine centres along the Belt and Road trail had increased to 32 in the wake of the release of the Development Plan of the Belt and Road for Traditional Chinese Medicine (2016-2020) last year. China would continue to foster exchanges, technological connectivity and trade with those countries, develop the Chinese medicine healthcare industry and promote the inheritance of and innovation in Chinese medicine.
In her speech, Professor Sophia Chan pointed out that the HKSAR Government is committed to the development of Chinese medicine. Following the announcement made in the latest Policy Address on the establishment of a unit to coordinate and implement strategies and measures to promote the development of Chinese medicine in Hong Kong, the Government has reserved funding of HK$5 billion to support the development of Chinese medicine in Hong Kong.